Telix Pharmaceuticals Ltd banner

Telix Pharmaceuticals Ltd
OTC:TLPPF

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
OTC:TLPPF
Watchlist
Price: 11.06 USD Market Closed
Market Cap: $3.7B

Wall St Price Targets

TLPPF Price Targets Summary
Telix Pharmaceuticals Ltd

Wall Street analysts forecast TLPPF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLPPF is 18.38 USD with a low forecast of 13.57 USD and a high forecast of 25.08 USD.

Lowest Forecast
Price Target
13.57 USD
23% Upside
Average Forecast
Price Target
18.38 USD
66% Upside
Highest Forecast
Price Target
25.08 USD
127% Upside
Telix Pharmaceuticals Ltd Competitors:
Price Targets
WOOF
Petco Health and Wellness Company Inc
28% Upside
AMAL
Amalgamated Bank
12% Upside
HCAT
Health Catalyst Inc
32% Upside

Revenue
Forecast

228% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
228% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 7 years, the compound annual growth rate for Revenue has been 228%. The projected CAGR for the next 8 years is 12%.

Operating Income
Forecast

N/A
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
38%
Average Beat
N/A
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
38%
Average Beat

The compound annual growth rate for Operating Income over the next 8 years is 41%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
26%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
26%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TLPPF's stock price target?
Price Target
18.38 USD

According to Wall Street analysts, the average 1-year price target for TLPPF is 18.38 USD with a low forecast of 13.57 USD and a high forecast of 25.08 USD.

What is the Revenue forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
12%

Over the last 7 years, the compound annual growth rate for Revenue has been 228%. The projected CAGR for the next 8 years is 12%.

What is the Operating Income forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
41%

The compound annual growth rate for Operating Income over the next 8 years is 41%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett